Our products are widely recognized and trusted by users and can meet continuously changing economic and social needs of Antibacterial Coating, 2 6-Di-O-Methyl-Beta_X005fCyclodextrin, Uv/Light Curing Coating, We've been not pleased while using the present achievements but we are trying finest to innovate to satisfy buyer's much more personalized needs. No matter where you will be from, we have been here to wait for your sort ask for, and welcom to go to our manufacturing facility. Choose us, you can meet your trusted supplier.
Fixed Competitive Price Sterilization Of Water - 3′-Amino-2′-hydroxy-[1,1'-bipheny]-3-carboxylic acid – JIN DUN Detail:
3′-Amino-2′-hydroxy-[1,1'-bipheny]-3-carboxylic acid is used as the intermediate of Eltrombopag .
Eltrombopag, developed by GlaxoSmithKline (GSK) in the UK and later jointly developed with Novartis in Switzerland, is the first and only approved small molecule non peptide TPO receptor agonist in the world. Eltrombopag was approved by the US FDA in 2008 for the treatment of idiopathic thrombocytopenic purpura (ITP), and in 2014 for the treatment of severe aplastic anemia (AA). It is also the first drug approved by the US FDA for the treatment of AA in recent 30 years.
In december2012, the US FDA approved Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C (CHC), so that hepatitis C patients with poor prognosis due to low platelet count can start and maintain interferon based standard therapy for liver diseases. On february3,2014, GlaxoSmithKline announced that the FDA granted the breakthrough treatment drug qualification of Eltrombopag for the treatment of hemopenia in patients with severe chemicalbook aplastic anemia (SAA) who did not fully respond to immunotherapy. On August 24, 2015, the US FDA approved Eltrombopag for the treatment of thrombocytopenia in adults and children aged 1 year and over with chronic immune thrombocytopenia (ITP) who have insufficient response to corticosteroids, immunoglobulins or splenectomy. On january4,2018, Eltrombopag was approved to be listed in China for the treatment of primary immune thrombocytopenia (ITP).
Product detail pictures:
Related Product Guide:
Usually customer-oriented, and it's our ultimate focus on to be not only by far the most reliable, trustable and honest provider, but also the partner for our customers for Fixed Competitive Price Sterilization Of Water - 3′-Amino-2′-hydroxy-[1,1'-bipheny]-3-carboxylic acid – JIN DUN , The product will supply to all over the world, such as: Cape Town, Argentina, Tunisia, We take measure at any expense to achieve essentially the most up-to-date equipment and approaches. The packing of nominated brand is our a further distinguishing feature. The items to assure years of trouble-free service has attracted a great deal customers. The solutions are obtainable in improved designs and richer assortment, they're created scientifically of purely raw supplies. It readily available in a variety of designs and specifications for your selection. The most recent kinds are a great deal better than the preceding one particular and they are quite popular with lots of prospects.